Nombre del producto:6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide

IUPAC Name:6-hydroxy-N,2-dimethyl-1-benzofuran-3-carboxamide

CAS:638217-08-0
Fórmula molecular:C11H11NO3
Pureza:97%
Número de catálogo:CM160779
Peso molecular:205.21

Unidad de embalaje Stock disponible Precio($) Cantidad
CM160779-1g in stock ưǯŢ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :638217-08-0
Fórmula molecular:C11H11NO3
Punto de fusión:-
Código de sonrisas:CNC(=O)C1=C(C)OC2=C1C=CC(O)=C2
Densidad:
Número de catálogo:CM160779
Peso molecular:205.21
Punto de ebullición:259.1°C at 760 mmHg
Nº Mdl:MFCD09836137
Almacenamiento:Store at 2-8°C.

Category Infos

Benzofurans
Benzofuran is an aromatic heterocyclic organic compound with the chemical formula C8H6O. It is a colorless oily liquid at room temperature with an aromatic odor. Benzofuran can be volatilized with water vapor and can be decomposed by potassium permanganate and other oxidants. It is an intermediate for the preparation of amiodarone and indene resin. Benzofuran derivatives are important pharmaceutical intermediates.
Benzofuran | C8H6O | CID 9223 -Chemenu
Benzofuran | C8H6O | CID 9223 |Where to Buy Benzofurans
Benzofuran is the heterocyclic compound consisting of fused benzene and furan rings. This colourless liquid is a component of coal tar.Benzofuran is extracted from coal tar. It is also obtained by dehydrogenation of 2-ethylphenol.

Column Infos

Fruquintinib
November 08, 2023, FDA has approved FRUZAQLA(fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
FRUZAQLA is the first and only selective inhibitor of all three VEGF receptor kinases approved in the U.S. for previously treated mCRC regardless of biomarker status.

Related Products